Evidence map›Paper›PMID 9618515›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.

G J Randolph, S Beaulieu, M Pope, I Sugawara, L Hoffman, R M Steinman, W A Muller

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04096222 (Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04096222 unknown statusnot on this mapstarted 2021, after this paper: background citation

Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

TypeobservationalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2021 to 2023Enrolled42ConditionsPemphigus Vulgaris, Bullous Dermatoses, Autoimmune Diseases
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 233 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. The Role of ABC Transporters in Skin Cells Exposed to UV Radiation.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  16. Article
  17. Schistosome ABC multidrug transporters: From pharmacology to physiology.International journal for parasitology. Drugs and drug resistance · 2014
    Review
  18. P-glycoprotein and drug resistance in systemic autoimmune diseases.International journal of molecular sciences · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

G J RandolphDepartment of Pathology, Cornell University Medical College, 1300 York Avenue, New York, NY 10021, USA. GJRandolph@mail.med.cornell.edu
S Beaulieu
M Pope
I Sugawara
L Hoffman
R M Steinman
W A Muller
Cornell University · USRockefeller University · US

Funding

Properties of Mouse of Dendritic Cells and MacrophagesR01AI013013 · NIAID · ROCKEFELLER UNIVERSITY · PI MOJSOV, SVETLANA · 1985 to 2015
$8.9M
TWO NOVEL VASCULAR ADHESION MOLECULES: PECAM AND HEC-1R01HL046849 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 1991 to 2019
$6.7M
Dendritic Cells and the Pathogenesis of HIV-1 InfectionR37AI040045 · NIAID · ROCKEFELLER UNIVERSITY · PI STEINMAN, RALPH MARVIN · 2001 to 2010
$6.1M
Identification and vaccine adjuvant responses of dendritic cells in humansR56AI040045 · NIAID · ROCKEFELLER UNIVERSITY · PI SCHLESINGER, SARAH JANE · 2011 to 2011
$520k
DENDRITIC CELLS AND THE PATHOGENESIS OF HIV-1 INFECTIONR01AI040045 · NIAID · ROCKEFELLER UNIVERSITY · PI STEINMAN, RALPH M. · 1996 to 2000
$457k
CLEARANCE OF MACROPHAGES FROM SITES OF INFLAMMATIONF32HL009722 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI RANDOLPH, GWENDALYN J · 1996 to 1998
–
PROPERTIES OF MOUSE DENDRITIC CELLS AND MACROPHAGESR37AI013013 · NIAID · ROCKEFELLER UNIVERSITY · PI STEINMAN, RALPH M. · 1986 to 1995
–
NHLBI NIH HHS F32 HL009722NHLBI NIH HHS HL46849NHLBI NIH HHS R01 HL046849NIAID NIH HHS AI13013NIAID NIH HHS AI40045NIAID NIH HHS N01 AI040045NIAID NIH HHS R01 AI013013
6 · The paper itself

Abstract

P-glycoprotein (MDR-1) is a well-known transporter that mediates efflux of chemotherapeutic agents from the intracellular milieu and thereby contributes to drug resistance. MDR-1 also is expressed by nonmalignant cells, including leukocytes, but physiologic functions for MDR-1 are poorly defined. Using an initial screening assay that included >100 mAbs, we observed that neutralizing mAbs MRK16, UIC2, and 4E3 against MDR-1 specifically and potently blocked basal-to-apical transendothelial migration of mononuclear phagocytes, a process that may mimic their migration into lymphatic vessels. Antagonists of MDR-1 then were used in a model of authentic lymphatic clearance. In this model, antigen-presenting dendritic cells (DC) migrate out of explants of cultured human skin and into the culture medium via dermal lymphatic vessels. DC and T cells derived from skin expressed MDR-1 on their surfaces. Addition of anti-MDR-1 mAbs MRK16, UIC2, or the MDR-1 antagonist verapamil to skin explants at the onset of culture inhibited the appearance of DC, and accompanying T cells, in the culture medium by approximately 70%. Isotype-matched control mAbs against other DC molecules including CD18, CD31, and major histocompatibility complex I did not block. In the presence of MDR-1 antagonists, epidermal DC were retained in the epidermis, in contrast to control conditions. In summary, this work identifies a physiologic function for MDR-1 during the mobilization of DC and begins to elucidate how these critical antigen-presenting cells migrate from the periphery to lymph nodes to initiate T lymphocyte-mediated immunity.

Indexed as

ATP Binding Cassette Transporter, Subfamily B, Member 1Cell MovementCells, CulturedCoculture TechniquesDendritic CellsEndothelium, VascularHumansLymphatic SystemSkinATP Binding Cassette Transporter, Subfamily B, Member 1

Identifiers

PMID9618515
PMCPMC22688
OpenAlexW2065456444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.